Leading the Way in Life Science Technologies

GEN Exclusives

More »

The Lists

More »
Apr 2, 2013

Top 22 R&D Spenders among Tool and Technologies Companies

Find out how much money goes into developing the instruments you use for research.

Top 22 R&D Spenders among Tool and Technologies Companies

These tool and tech providers are investing the most in R&D among those in the biotechnology arena. [Natalia Merzlyakova - Fotolia.com]

  • A few weeks ago, GEN presented you with a list of the top 20 biopharma R&D spenders. However, drug discovery is only part of the R&D story; what about the companies that make the technology that makes drug discovery possible? Following is a list of top 25 life sciences tools and technologies providers—including both companies and divisions of broader corporate giants—as ranked by their R&D spending for 2012. Listings include R&D spending for 2012 and 2011, the percentage difference between the two years, the percentage of sales for both years, and 2008 R&D spending and percentage of sales.

  • #22. Fluidigm

    2012 R&D spending: $16.602 million

    2011 R&D spending: $13.936 million

    % Change: 19.1%

    2012 percentage of revenues: 31.7%

    2011 percentage of revenues: 32.5%

  • #21. Eppendorf International

    2012 R&D spending: $35.233 million (€27.5 million)1,2

    2011 R&D spending: $31.823 million (€24.838 million)2

    % Change: 10.7%

    2012 percentage of sales: 5.3%

    2011 percentage of sales: 5.2%

  • #20. Sartorius Stedim Biotech

    2012 R&D spending: $39.683 million (€30.972 million)3

    2011 R&D spending: $36.616 million (€28.580 million)3

    % Change: 8.4%

    2012 percentage of sales revenue: 5.7%

    2011 percentage of sales revenue: 6.0%

  • #19. Sequenom

    2012 R&D spending: $54.115 million

    2011 R&D spending: $53.585 million

    % Change: 1.0%

    2012 percentage of revenues: 60.3%

    2011 percentage of revenues: 95.8%

  • #18. Affymetrix

    2012 R&D spending: $57.881 million

    2011 R&D spending: $63.591 million

    % Change: -9.0%

    2012 percentage of revenues: 19.6%

    2011 percentage of revenues: 23.8%

  • #17. Sigma-Aldrich

    2012 R&D spending: $69 million

    2011 R&D spending: $72 million

    % Change: 4.2%

    2012 percentage of revenues: 2.6%

    2011 percentage of revenues: 2.9%

  • #16. Cepheid

    2012 R&D spending: $71.673 million

    2011 R&D spending: $59.362 million

    % Change: 20.7

    2012 percentage of revenues: 21.6%

    2011 percentage of revenues: 21.4%

  • #15. Waters

    2012 R&D spending: $96.004 million

    2011 R&D spending: $92.347 million

    % Change: 4.0%

    2012 percentage of net sales: 5.2%

    2011 percentage of net sales: 5.0%

  • #14. Mettler-Toledo International

    2012 R&D spending: $112.530 million

    2011 R&D spending: $116.139 million

    % Change: -3.1%

    2012 percentage of net sales: 4.8%

    2011 percentage of net sales: 5.0%

  • #13. Qiagen

    2012 R&D spending: $122.476 million

    2011 R&D spending: $130.636 million

    % Change: -6.2%

    2012 percentage of net sales: 9.8%

    2011 percentage of net sales: 11.2%

  • #12. PerkinElmer

    2012 R&D spending: $132.639 million

    2011 R&D spending: $115.821 million

    % Change: 14.5%

    2012 percentage of revenues: 6.3%

    2011 percentage of revenues: 6.0%



Related content

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »